US$ 63.93
Quantity: 1 available
Add to basketCondition: Very Good. Most items will be dispatched the same or the next working day. A copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
hardcover. Condition: New. In shrink wrap. Looks like an interesting title!
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 596 | Sprache: Englisch | Produktart: Bücher | The prevalence of dementia increases greatly with age so, with increasing numbers surviving to old age, Alzheimer?s disease has reached epidemic proportions, and this trend will increase in the future. The disease is therefore having a significant effect on escalating health care costs. Meanwhile, drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried out. All these factors have important cost implications but it has been difficult to draw any consistent conclusions from studies so far. This book will become the standard reference work in the subject. It provides a sound introduction to the disease, its epidemiology, care implications, and the development and use of drugs. It discusses the challenges of obtaining reliable data, and reviews the tools used to assess the outcomes and costs of dementia to date. It also deals with the pharmacoeconomics of the disease, making it essential reading for all those who work with patients with dementia as well as for professionals in the pharmaceutical industry. This volume is: The first major text of its type to address this important area Written by internationally well-known researchers in this field A well-constructed, comprehensive and up-to-date volume providing a wealth of information.
Condition: New.
Condition: As New. Unread book in perfect condition.
US$ 530.71
Quantity: Over 20 available
Add to basketCondition: New.
US$ 529.33
Quantity: Over 20 available
Add to basketCondition: New. In.
US$ 553.60
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Language: English
Published by John Wiley & Sons Inc, New York, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: CitiRetail, Stevenage, United Kingdom
First Edition
US$ 574.28
Quantity: 1 available
Add to basketHardcover. Condition: new. Hardcover. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Condition: New.
Language: English
Published by John Wiley & Sons Inc, New York, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
First Edition
Hardcover. Condition: new. Hardcover. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
US$ 602.46
Quantity: Over 20 available
Add to basketGebunden. Condition: New. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs.
US$ 652.43
Quantity: 3 available
Add to basketCondition: New. pp. 596.
Condition: New. pp. 596 1st Edition.
Language: English
Published by John Wiley & Sons Inc, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
First Edition
US$ 714.91
Quantity: Over 20 available
Add to basketCondition: New. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. Editor(s): Winblad, Bengt; etc.; Wimo, Anders; Johnsson, Bengt (School of Health Economics, Bergjo, Sweden); Karlsonn, Goran (School of Health Economics, Bergjo, Sweden). Num Pages: 592 pages, forms. BIC Classification: MBP; MMH. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 245 x 168 x 36. Weight in Grams: 966. . 1998. 1st Edition. Hardcover. . . . .
Language: English
Published by John Wiley & Sons Inc, New York, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: AussieBookSeller, Truganina, VIC, Australia
First Edition
Hardcover. Condition: new. Hardcover. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Language: English
Published by John Wiley & Sons Inc, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: Revaluation Books, Exeter, United Kingdom
US$ 797.50
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 576 pages. 9.50x6.50x1.50 inches. In Stock.
Language: English
Published by John Wiley & Sons Inc, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. Editor(s): Winblad, Bengt; etc.; Wimo, Anders; Johnsson, Bengt (School of Health Economics, Bergjo, Sweden); Karlsonn, Goran (School of Health Economics, Bergjo, Sweden). Num Pages: 592 pages, forms. BIC Classification: MBP; MMH. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 245 x 168 x 36. Weight in Grams: 966. . 1998. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Buch. Condition: Neu. Neuware - The prevalence of dementia increases greatly with age so, with increasing numbers surviving to old age, Alzheimer's disease has reached epidemic proportions, and this trend will increase in the future. The disease is therefore having a significant effect on escalating health care costs. Meanwhile, drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried out. All these factors have important cost implications but it has been difficult to draw any consistent conclusions from studies so far. This book will become the standard reference work in the subject. It provides a sound introduction to the disease, its epidemiology, care implications, and the development and use of drugs. It discusses the challenges of obtaining reliable data, and reviews the tools used to assess the outcomes and costs of dementia to date. It also deals with the pharmacoeconomics of the disease, making it essential reading for all those who work with patients with dementia as well as for professionals in the pharmaceutical industry. This volume is:
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
US$ 539.05
Quantity: Over 20 available
Add to basketHRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Language: English
Published by John Wiley & Sons Inc, 1998
ISBN 10: 0471983764 ISBN 13: 9780471983767
Seller: Revaluation Books, Exeter, United Kingdom
US$ 751.03
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 576 pages. 9.50x6.50x1.50 inches. In Stock. This item is printed on demand.